Annual report pursuant to Section 13 and 15(d)

Composition of Certain Financial Statement Captions (Details 3)

v3.3.1.900
Composition of Certain Financial Statement Captions (Details 3) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Goodwill [Roll Forward]    
Beginning balance $ 224,292 [1] $ 226,373
Acquisitions 524,531 0
Foreign exchange, other (5,475) (2,081)
Ending balance [1] 743,348 224,292
OPKO Biologics    
Goodwill [Roll Forward]    
Ending balance 139,784  
OPKO Chile    
Goodwill [Roll Forward]    
Ending balance 5,441  
OPKO Health Europe    
Goodwill [Roll Forward]    
Ending balance 8,062  
OPKO Renal    
Goodwill [Roll Forward]    
Ending balance 2,411  
Bio-Reference Laboratories, Inc.    
Goodwill [Roll Forward]    
Ending balance 441,158  
OPKO Lab    
Goodwill [Roll Forward]    
Ending balance 29,629  
Pharmaceutical | CURNA    
Goodwill [Roll Forward]    
Beginning balance 4,827 4,827
Acquisitions 0 0
Foreign exchange, other 0 0
Ending balance 4,827 4,827
Pharmaceutical | EirGen Pharma Limited    
Goodwill [Roll Forward]    
Beginning balance 0 0
Acquisitions 83,373 0
Foreign exchange, other (2,234) 0
Ending balance 81,139 0
Pharmaceutical | FineTech    
Goodwill [Roll Forward]    
Beginning balance 11,698 11,698
Acquisitions 0 0
Foreign exchange, other 0 0
Ending balance 11,698 11,698
Pharmaceutical | OPKO Biologics    
Goodwill [Roll Forward]    
Beginning balance 139,784 139,784
Acquisitions 0 0
Foreign exchange, other 0 0
Ending balance 139,784 139,784
Pharmaceutical | OPKO Chile    
Goodwill [Roll Forward]    
Beginning balance 5,283 6,102
Acquisitions 0 0
Foreign exchange, other (766) (819)
Ending balance 4,517 5,283
Pharmaceutical | OPKO Health Europe    
Goodwill [Roll Forward]    
Beginning balance 8,013 9,075
Acquisitions 0 0
Foreign exchange, other (822) (1,062)
Ending balance 7,191 8,013
Pharmaceutical | OPKO Mexico    
Goodwill [Roll Forward]    
Beginning balance 100 114
Acquisitions 0 0
Foreign exchange, other (100) (14)
Ending balance 0 100
Pharmaceutical | OPKO Renal    
Goodwill [Roll Forward]    
Beginning balance 2,069 2,069
Acquisitions 0 0
Foreign exchange, other 0 0
Ending balance 2,069 2,069
Pharmaceutical | SciVac    
Goodwill [Roll Forward]    
Beginning balance 1,553 1,739
Acquisitions 0 0
Foreign exchange, other (1,553) (186)
Ending balance 0 1,553
Diagnostics | Bio-Reference Laboratories, Inc.    
Goodwill [Roll Forward]    
Beginning balance 0 0
Acquisitions 441,158 0
Foreign exchange, other 0 0
Ending balance 441,158 0
Diagnostics | OPKO Diagnostics    
Goodwill [Roll Forward]    
Beginning balance 17,977 17,977
Acquisitions 0 0
Foreign exchange, other 0 0
Ending balance 17,977 17,977
Diagnostics | OPKO Lab    
Goodwill [Roll Forward]    
Beginning balance 32,988 32,988
Acquisitions 0 0
Foreign exchange, other 0 0
Ending balance $ 32,988 $ 32,988
[1] As of December 31, 2014, total assets include $7.6 million and total liabilities include $12.1 million related to SciVac Ltd (“SciVac”). SciVac was a consolidated variable interest entity which we deconsolidated in July 2015. Refer to Note 4. SciVac’s consolidated assets were owned by SciVac and SciVac’s consolidated liabilities had no recourse against us.